cagrilintide tirzepatide combination study + Semaglutide Blend cagrilintide tirzepatide combination trial What's

Pancreatitis/Necrotizing pancreatitis Pancreatitis is a potentially life-threatening inflammation of the pancreas

Rather, we help you rebalance it

But the study stopped giving the drug at 12 weeks

Once you start this medication, you need to regularly check with your healthcare team as they'll need to track your: Weight changes Nutritional status through blood tests Blood sugar levels, especially for diabetics Any side effects you're experiencing Overall health and well-being Your provider might recommend more frequent nutritional lab work than what's typically scheduled for post-bariatric patients, just to make sure you're not developing any deficiencies